Page last updated: 2024-09-05

N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide and pemetrexed

N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide has been researched along with pemetrexed in 1 studies

Compound Research Comparison

Studies
(N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide)
Trials
(N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide)
Recent Studies (post-2010)
(N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide)
Studies
(pemetrexed)
Trials
(pemetrexed)
Recent Studies (post-2010) (pemetrexed)
9072,4696571,695

Protein Interaction Comparison

ProteinTaxonomyN-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide (IC50)pemetrexed (IC50)
Thymidylate synthase Escherichia coli1.1
Dihydrofolate reductaseHomo sapiens (human)4.0309
Dihydrofolate reductaseLacticaseibacillus casei2.3
Thymidylate synthaseHomo sapiens (human)8.1787
Dihydrofolate reductaseEscherichia coli K-122.3
Folate receptor betaHomo sapiens (human)0.2585
Folate receptor alphaHomo sapiens (human)0.2417
Trifunctional purine biosynthetic protein adenosine-3Homo sapiens (human)0.0342
Bifunctional purine biosynthesis protein ATICHomo sapiens (human)0.07
Reduced folate transporterHomo sapiens (human)0.0928
Bifunctional dihydrofolate reductase-thymidylate synthaseToxoplasma gondii1.655
Proton-coupled folate transporterHomo sapiens (human)0.0229

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

1 other study(ies) available for N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide and pemetrexed

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013